UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

PloS one, 2015-09, Vol.10 (9), p.e0139073

2015

Volltextzugriff (PDF)

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension

American journal of respiratory and critical care medicine, 2010-01, Vol.181 (2), p.158-167

2010

Volltextzugriff (PDF)

Evaluation of Angiogenesis Using Micro-Computed Tomography in a Xenograft Mouse Model of Lung Cancer

Neoplasia (New York, N.Y.), 2009-01, Vol.11 (1), p.48-56

2009

Volltextzugriff (PDF)

Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension

American journal of respiratory and critical care medicine, 2008-07, Vol.178 (2), p.188-196

2008

Volltextzugriff (PDF)

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4

Molecular biology of the cell, 2009-11, Vol.20 (22), p.4751-4765

2009

Volltextzugriff (PDF)

Targeting cancer with phosphodiesterase inhibitors

Expert opinion on investigational drugs, 2010-01, Vol.19 (1), p.117-131

2010

Volltextzugriff (PDF)

Dendritic cells fused with core binding factor‐beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes

British journal of haematology, 2004-08, Vol.126 (4), p.593-601

2004

Volltextzugriff (PDF)

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma

Supportive care in cancer, 2007-07, Vol.15 (7), p.877-884

2007

Volltextzugriff (PDF)

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation

Cancer Immunology, Immunotherapy, 2013-02, Vol.62 (2), p.309-320

2013

Volltextzugriff (PDF)

Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?

Histology and histopathology, 2013-06, Vol.28 (6), p.691

2013

Volltextzugriff (PDF)

A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (11), p.5443-5453

2007

Volltextzugriff (PDF)

Empirische Befunde zur Verlegungspraxis Sterbender

MMW Fortschritte der Medizin, 2017-10, Vol.159 (Suppl 6), p.6-14

2017

Volltextzugriff (PDF)

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4

Molecular biology of the cell, 2022-08, Vol.33 (9), p.1-cor2

2022

Volltextzugriff (PDF)

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

British journal of haematology, 2015-03, Vol.168 (6), p.824-834

2015

Volltextzugriff (PDF)

Rituximab combined with Dexa BEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

British journal of haematology, 2015-03, Vol.168 (6), p.824-834

2015

Volltextzugriff (PDF)

Hybrid-primed lymphocytes and hybrid vaccination prevent tumor growth of lewis lung carcinoma in mice

Journal of immunotherapy, 2006-03, Vol.29 (2), p.175-187

2006

Volltextzugriff (PDF)

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent and mantle cell lymphomas (MCL): Updated results from the StiL NHL1 study

Journal of clinical oncology, 2012-06, Vol.30 (18_suppl), p.3-3

2012

Volltextzugriff (PDF)

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent and mantle cell lymphomas (MCL): Updated results from the StiL NHL1 study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.3-3

2012

Volltextzugriff (PDF)

Evaluation of Humoral Immune Responses to Vaccination with Tetanus Toxoid and KLH in Rituximab-Treated Follicular Non-Hodgkin's Lymphoma Patients Compared to Healthy Volunteers

Blood, 2008-11, Vol.112 (11), p.3066-3066

2008

Volltextzugriff (PDF)

Abstract 1839: Phosphodiesterase 4 regulates lung tumor growth through HIF regulation, proliferation, and angiogenesis

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1839-1839

2012

Volltextzugriff (PDF)

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer

Expert opinion on investigational drugs, 2011-01, Vol.20 (1), p.61-74

2011

Volltextzugriff (PDF)

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma: e0139073

PloS one, 2015-09, Vol.10 (9)

2015

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(14)
Animals
(11)
Mice
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Oncology
(6)
Female
(4)
Internal Medicine
(4)
Patients
(4)
Aged
(3)
Antineoplastic Agents
(3)
Antineoplastic Agents - Pharmacology
(3)
Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage
(3)
Cell Biology
(3)
Dendritic Cells - Immunology
(3)
Disease Models, Animal
(3)
General & Internal Medicine
(3)
Hematology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension

Evaluation of Angiogenesis Using Micro-Computed Tomography in a Xenograft Mouse Model of Lung Cancer

Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4

Targeting cancer with phosphodiesterase inhibitors

Dendritic cells fused with core binding factor‐beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation

Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis?

A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells

Empirische Befunde zur Verlegungspraxis Sterbender

Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: The role of phosphodiesterase 4

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

Rituximab combined with Dexa BEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

Hybrid-primed lymphocytes and hybrid vaccination prevent tumor growth of lewis lung carcinoma in mice

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent and mantle cell lymphomas (MCL): Updated results from the StiL NHL1 study

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent and mantle cell lymphomas (MCL): Updated results from the StiL NHL1 study

Evaluation of Humoral Immune Responses to Vaccination with Tetanus Toxoid and KLH in Rituximab-Treated Follicular Non-Hodgkin's Lymphoma Patients Compared to Healthy Volunteers

Abstract 1839: Phosphodiesterase 4 regulates lung tumor growth through HIF regulation, proliferation, and angiogenesis

Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer

Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma: e0139073

Suchergebnisse filtern